You are reading: Healthy Participants | The Respiratory Virus Vaccine Study (Visits Only)

Healthy Participants

The Respiratory Virus Vaccine Study (Visits Only)

Start date

Various Dates Available

Remuneration

$4,800

8-9 appointments, 1-2 phone calls

Help Test a New Vaccine
for Respiratory Viruses

This clinical study is evaluating a potential new vaccine designed to provide broad protection against sarbecoviruses, a subgroup of coronaviruses that includes SARS-CoV-1 and SARS-CoV-2.

Healthy adults who are fully vaccinated against COVID-19 are invited to take part. This study involves day visits only and does not require an overnight clinic stay. By participating, you will help researchers understand the potential effects of this new vaccine and support ongoing research.

The study vaccine contains harmless fragments of viral proteins made using recombinant technology. It is designed to train the immune system to recognise and respond to multiple sarbecoviruses.

This is a randomised, double-blind, active-controlled trial where participants receive either the study vaccine, a placebo, or an approved COVID-19 vaccine.

Apply Now

Example Schedule

8 appointments

Day 1, Day 8, Day 15, Day 29, Day 43, Day 57, Day 113, Day 197, Day 364

To Qualify, You Must

Age

Be 18 to 55 years old

Gender

Both males or females

Physical Condition

Have no significant medical health conditions or allergies

Requirements

Have a BMI between 18 and 32kg/m2

Remuneration

$4,800

Help Test a New Vaccine for Respiratory Viruses.

Spots are limited. Find out if you qualify today!

Apply Now